The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.

Fischer & Waxman Familial syndromes in the Na v1.7 channel multiple, distinct sodium currents, which can be distinguished from one another by their differ-

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by , 2016-03-30 03:33:02

Familial pain syndromes from mutations of the Nav1.7 ...

Fischer & Waxman Familial syndromes in the Na v1.7 channel multiple, distinct sodium currents, which can be distinguished from one another by their differ-

Ann. N.Y. Acad. Sci. ISSN 0077-8923

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES

Familial pain syndromes from mutations of the Nav1.7
sodium channel

Tanya Z. Fischer1,2,3 and Stephen G. Waxman1,2,3

1Department of Neurology and 2Center for Neuroscience & Regeneration Research, Yale University School of Medicine,
New Haven, Connecticut, USA. 3Rehabilitation Research Center, Veterans Administration Connecticut Healthcare System,
West Haven, Connecticut, USA

Address for correspondence: Stephen G. Waxman, M.D., Ph.D., Department of Neurology, LCI 707, Yale School of Medicine,
333 Cedar Street, New Haven, CT 06510. Voice: 203-785-6351; fax: 203-785-2238. [email protected]

The literature currently suggests that voltage-gated sodium channels play a major role in the pathogenesis of neuro-
pathic pain. Alterations in the expression and targeting of specific sodium channels within injured dorsal root ganglia
neurons appear to predispose the neurons to abnormal firing properties, allowing for the development of neuropathic
pain. Mutations of one particular sodium channel (Nav1.7) have been shown to cause inherited neuropathic pain
in humans, specifically in erythromelalgia and paroxysmal extreme pain disorder. Inherited erythromelalgia is the
first human pain syndrome to be understood at a molecular level, having been linked to gain-of-function mutations
of Nav1.7. Conversely, a loss-of-function of the Nav1.7 channel can produce channelopathy-associated insensitivity
to pain. Therefore, the Nav1.7 channel may provide a unique target for the pharmacotherapy of pain in humans. In
this review article we summarize current knowledge regarding several different disease manifestations arising from
changes within the Nav1.7 channel.

Keywords: neuropathic pain; sodium channels; erythromelalgia; paroxysmal extreme pain disorder; channelopathy-
associated insensitivity to pain; dorsal root ganglion; voltage clamp

Introduction for brevity, we will refer to as sodium channels
(Nav). Although the literature indicates that there
Primary nociceptive or pain-signaling sensory neu- are multiple sodium channels, only seven (Nav1.1,
rons, specifically within dorsal root ganglia (DRG) Nav1.2, Nav1.3, Nav1.6, Nav1.7, Nav1.8, and Nav1.9)
and trigeminal ganglia, constitute the peripheral en- have been found in the nervous system.11 These
try point of the pain pathway. Usually, these neurons different sodium channels share a common struc-
are relatively quiescent. When stimulated, these neu- ture but are encoded by different genes and mani-
rons produce a series of action potentials, allowing fest distinct voltage-dependent and kinetic proper-
information about the external sensory world to be ties. Sodium channels are expressed in a regionally
transmitted to the brain. Injury to these neurons and temporally specific pattern in the nervous sys-
causes them to become hyperexcitable, thus giving tem. Interestingly, the majority of neurons express
rise to abnormal, unprovoked spontaneous action multiple sodium channel isoforms, with different
potentials or pathological bursting, which results in ensembles of sodium channel isoforms endowing
chronic pain.1–4 different types of neurons with unique functional
properties.12
In mammalian neurons, voltage-gated sodium
channels produce action potentials in response to Multiple sodium channels in dorsal root
membrane depolarization. Sodium channels are ganglia neurons
composed of a single ␣-subunit and several aux-
iliary ␤-subunits.5 The ␣-subunit endows the chan- It has been well established through early elec-
nel with voltage sensitivity and forms the ion- trophysiologic studies that DRG neurons produce
selective pore, while the ␤-subunits appear to
influence channel gating and targeting.6–10 Here
we focus on sodium channel ␣-subunits which,

196 Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences.

Fischer & Waxman Familial syndromes in the Nav1.7 channel

multiple, distinct sodium currents, which can be treme pain disorder (PEPD). Conversely, several
cases have been described in the literature of other-
distinguished from one another by their differ- wise healthy patients with a congenital inability to
experience pain, arising from nonsense mutations
ences in voltage dependence, kinetics, and sensitiv- of Nav1.7, which produce truncated, nonfunctional
ity to the neurotoxin tetrodotoxin (TTX).13–16 Im- proteins.32–34 These various studies, both in ani-
mals and in humans, have helped to establish ion
portantly, multiple distinct sodium currents have channels, especially Nav1.7, as a major factor of pe-
ripheral nociception.
been recorded from individual neurons, suggesting
Inherited erythromelalgia
that multiple types of sodium channels are present
within them.17,18 IEM, originally described by S. Weir Mitchell in
1878,35 is characterized by intense episodic burn-
Of the known neuronally expressed sodium chan- ing pain associated with redness and warmth of the
affected extremities. In the absence of an underly-
nels, Nav1.7, Nav1.8, and Nav1.9 are preferentially ing cause (such as in myeloproliferative diseases or
expressed in DRG and trigeminal ganglia neu- as a side effect of medication), it is termed primary
rons,19–22 most of which are nociceptive. The Nav1.7 erythromelalgia and in many instances occurs as an
channel is expressed in almost all DRG neurons at autosomal dominant trait (Mendelian Inheritance
various levels,20 while the Nav1.8 and Nav1.9 chan- in Man 133020).36 Clinical onset of the inherited
nels are primarily expressed in small DRG neu- form of this disease has been reported as early as
rons that include nociceptors.18,19,21 The Nav1.8 1 year of age, often manifesting itself before the
and Nav1.9 channels are also distinguished from the end of the first decade of life. Attacks are described
Nav1.7 channel by their resistance to TTX.18,19 Ex- by patients as a burning pain (which patients de-
pression of the Nav1.8 and Nav1.9 channels are both scribe as excruciating, “like hot lava poured into
downregulate in DRG neurons after sciatic nerve my body”) with accompanying redness in the dis-
tal extremities (feet, sometimes hands) in response
transection but are elevated under inflammatory to warm stimuli or moderate exercise.36 A charac-
conditions.21,23 Although Nav1.3 channels are not teristic feature is relief obtained by immersing the
expressed above background levels in adult DRG extremities in ice, which can lead to ulceration and
gangrene. In the absence of a clear etiology, treat-
neurons, the Nav1.3 channel has been shown to be ment has been empirical and is partially effective
upregulated in DRG neurons following injury.24,25 at best. IEM shares a number of clinical features
with, and is sometimes confused with, reflex sym-
Therefore, along with the Nav1.8 and Nav1.9 chan- pathetic dystrophy (RSD) since both are character-
nels, Nav1.3 has been suggested to play a role in ized by severe pain and vasomotor disturbances,
neuropathic pain. but in contrast to RSD, erythromelalgia is bilateral
and symmetric.35–38 Since attacks are episodic and
Multiple studies have shown the importance of can be counted, IEM appears to provide a human
model that is especially tractable for therapeutic
voltage-gated ion channels in the perception and trials.
transmission of pain.26,27 For example, a mouse
Mutations of Nav1.7: genetic analysis
knockout model of the voltage-gated Nav1.8 chan- and expression studies
nel results in animals with deficits of thermal
pain perception28 and visceral pain perception29 Importantly, IEM is the first known inherited
but not neuropathic pain.30 When Nav1.7 is selec- painful neuropathy to be examined at a molecular
tively knocked out of nociceptive neurons, the mice level. Until recently the pathogenesis of this disease

display markedly reduced inflammatory pain re-

sponses and a deficit in heat-induced pain threshold,

while the mechanical pain and cold-evoked thresh-
olds appear to be intact.31 On the other hand, in

mice, global knockout of Nav1.7 has been found to
be lethal,31 possibly due to a failure to feed. Interest-

ingly, when both Nav1.7 and Nav1.8 channels were
knocked out of mice, alterations only in inflamma-
tory pain were seen.30

In humans, point mutations within the SCN9A

gene, which codes for the Nav1.7 channel, have
been associated with two different pain syndromes

caused by a “gain-in-function” of the channel: in-

herited erythromelalgia (IEM) and paroxysmal ex-

Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences. 197

Familial syndromes in the Nav1.7 channel Fischer & Waxman

was unknown. Hypotheses encompassing vascular Subsequent studies40,46,54 used current-clamp
recording to directly show that this mutation ren-
shunting, neuropathic etiologies, microvascular eti- ders sensory neurons hyperexcitable. When DRG
neurons, a cell type known to express Nav1.7 chan-
ologies, and inflammatory etiologies have all been nels,22,48,49 are transfected with WT Nav1.7 chan-
nels, they produce all-or-none action potentials in
suggested. response to injections of 135 pA or greater (Fig. 2A).
In 2004, Yang and coworkers,39 using linkage However, in DRG neurons expressing the L858H
IEM mutant channel, a much lower current input
analysis, identified two independent point muta- is required for the generation of an action potential
(Fig. 2B). The current threshold is significantly de-
tions in the gene encoding Nav1.7 in two separate creased, by more than 40%, in cells expressing IEM
families in China with IEM. A single amino-acid mutant channels, such as the L858H Nav1.7 muta-
tion, compared with WT Nav1.7 channels (Fig. 2C).
substitution (F1449V) was subsequently identified IEM mutations also enhance repetitive firing in
DRG neurons (Fig. 3B) compared with WT cells
in the Nav1.7 channel in another large American (Fig. 3A). These experiments show that an IEM mu-
family.40 In each of these kindreds, all affected family tation of Nav1.7 can produce hyperexcitability (de-
creased threshold and enhanced repetitive firing)
members carried this mutation, while it was absent within DRG neurons, providing a molecular expla-
nation for the pain experienced in patients with
in unaffected family members and in the alleles from IEM.

an ethnically matched control group. A number of Our group has found de novo “founder” mu-
tations that increase DRG neuron excitability in
other mutations, all in Nav1.7, have subsequently several sporadic cases of erythromelalgia, and thus
been found in other families with IEM.41–47 Thus has indicted Nav1.7 mutations in some individu-
als who do not have a family history of the dis-
far, penetrance appears to be close to 100% for IEM order.45,46 In addition, several mutations in the
mutations.39,40 gene for Nav1.7 have been found, which appear to
modulate the channel’s sensitivity to local anaes-
Consistent with a role in painful neuropathy, thetics.44,55,56 Choi and colleagues55 identified a
new Nav1.7 mutation, V872G, in a patient who re-
Nav1.7 channels are preferentially expressed in noci- ported pain relief with mexiletine and observed that
ceptive DRG neurons and their nerve endings.22,48,49 the mutation resulted in stronger use-dependent
current fall-off when the channels were exposed
In these neurons, Nav1.7 produces “threshold cur- to mexiletine. Fischer and colleagues44 reported a
rents” close to resting potential, amplifying small de- family with carbamazepine (CBZ)-responsive IEM
polarizations such as generator potentials,50,51 while and demonstrated that the mutation confers CBZ-
sensitivity in the mutant channel.
other sodium channel isoforms contribute most of
While missense mutations in Nav1.7 channel have
the current underlying all-or-none action poten- been found in many families with IEM, this dis-
tials.52 IEM mutations of Nav1.7 have been shown to ease may be genetically heterogeneous because some
cause a hyperpolarizing shift in activation and slow cases of familial early-onset57 or adult-onset58 IEM
deactivation43 (Fig. 1A and B). The hyperpolariz- do not have mutations in the coding exons of
SCN9A. To date, mutations within the coding re-
ing shift in the voltage dependence of activation of gions of the Nav1.8 channel and the Nav1.9 channel
have not been observed in these cases of IEM, sug-
the Nav1.7 channel (which makes it easier to open gesting that other target genes or mutations in the
the channel) and the slowed deactivation (which noncoding regions of SCN9A, the gene encoding
Nav1.7, may result in the IEM phenotype.
keeps the channel open longer once it is activated),

in turn, are expected to decrease the threshold for

action potential generation in sensory neurons, thus

increasing neuronal excitability. The response of

Nav1.7 channels to slow ramp depolarizations (e.g.,
0.2 mV/ms depolarizations from −100 to −20 mV)

(Fig. 1D) are also significantly enhanced compared
with wild-type (WT) channels.43 Because the ramp

currents are evoked close to the resting potential of
DRG neurons,13,53 the larger ramp currents in DRG

neurons expressing IEM mutations of Nav1.7 are
poised to amplify the response to small depolariz-

ing inputs. This, in turn, would increase excitability.

Nav1.7 channels are present in small, mostly noci-
ceptive, sensory neurons,48 suggesting that changes

in activation, deactivation, and ramp current am-

plitude contribute to the pain experienced by IEM

patients.

198 Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences.

Fischer & Waxman Familial syndromes in the Nav1.7 channel

Figure 1. The L858H mutation produces a gain-of-function in Nav1.7. (A) Schematic of the Nav1.7 channel. The
L858H mutation substitutes a single amino acid within the domain II/S4-S5 linker. (B) Cells expressing the mutant
L858H channel display a hyperpolarizing shift in activation. (C) Representative tail currents of WT and L858H
channels, showing that the mutant channel causes slow deactivation. (D) Time constants for tail current deactivation
are increased for L858H Nav1.7 channels. (E) Representative ramp currents in HEK293 cells expressing WT or
L858H channels, showing that cells expressing the mutant channel generate larger currents in response to small,
slow depolarizations. This may, in turn, allow for an earlier initiation of the action potential by the mutant channel.
(Adapted with permission from Cummins and colleagues.43 Panels B–D are from Fig. 1, and Panel E is from Fig. 3 of
that article.)

Paroxysmal extreme pain disorder attacks are most severe in the lower part of the body
and can be triggered by a bowel movement or prob-
A second autosomal dominant pain disorder, re- ing of the perianal area; they may also be accom-
sulting from a different set of gain-of-function panied by tonic nonepileptic seizures, bradycardia,
mutations that impair inactivation of Nav1.7, is and/or apnea, which appears to be more common
PEPD.59–61 Severe pain in PEPD patients, accom- in infancy and young children.62 The cause for the
panied by autonomic manifestations such as skin seizure-like activity and cardiac symptoms is not
flushing, can start as early as infancy.62 The pain well understood at this time. As the person ages, the

Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences. 199

Familial syndromes in the Nav1.7 channel Fischer & Waxman

pain symptoms often change, with pain primarily
affecting the ocular and maxillary and/or mandibu-
lar areas rather than the rectal area. These attacks
are often triggered by temperature changes (such as
cold winds), eating, and/or emotional upsets (such
as crying).62 Pain episodes usually last seconds to
minutes but may last for hours in extreme cases.
Between episodes, patients with PEPD complain of
constipation, which can be seen as early as infancy.
It has been speculated that this may be due to the pa-
tient’s fear of inducing a pain attack by the passage
of stool.62 Interestingly, most patients with PEPD
have a favorable response to treatment with CBZ.60
As with IEM, not all patients with the diagnosis of
PEPD carry mutations in Nav1.7.60

Mutations of Nav1.7: genetic analysis
and expression studies

The first described PEPD mutations, located in do-
main III and IV of Nav1.7, were reported in 2006
to impair fast-inactivation without altering chan-
nel activation, leading to a persistent current that
is attenuated by CBZ.60 Dib-Hajj and collabora-
tors59 extended the initial analysis to examine other
gating properties of the M1627K mutant Nav1.7
channel from a family with PEPD, showing that
the mutant channel recovers from fast-inactivation
faster than the WT channel and produces larger cur-
rents in response to ramp stimuli. Figure 4 shows
whole cell currents from representative human em-
bryonic kidney (HEK) cells expressing WT Nav1.7
(Fig. 4B) and the M1627K mutant channel (Fig. 4C),
elicited with a series of depolarizing test pulses. The
peak current-voltage relationship between the WT
channels and the mutant channels were about the
same (Fig. 5A), and the time constants for deac-
tivation were not altered for the M1627K channel
(Fig. 5B), indicating that the M1627K mutation does
not alter Nav1.7 activation properties. However, the
voltage-dependence of steady-state fast-inactivation

Figure 2. L858H renders DRG neurons hyperexcitable. ←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Representative traces from cells expressing WT Nav1.7 DRG neurons expressing WT Nav1.7 channels is signif-
(A) and the L858H IEM mutant channel (B) show that icantly greater than that of neurons expressing L858H
action potentials were evoked with smaller depolarizing mutant channels, indicating that the L858H mutation
stimuli in cells housing the mutant channel. (C) The renders sensory neurons hyperexcitable. (Adapted with
average current threshold for action potential firing of permission from Rush and colleagues.54 Panels A–C are
from Fig. 1 of that article.)

200 Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences.

Fischer & Waxman Familial syndromes in the Nav1.7 channel

Figure 3. The L858H mutation increases firing fre- Figure 4. Currents produced by PEPD mutant M1672K
quency in DRG neurons. (A) Representative DRG neuron decay slower than WT Nav1.7 currents. (A) Schematic of
expressing WT Nav1.7 fires a single action potential in the Nav1.7 channel. The M1627K substitution is located
response to a current injection. (B) Representative DRG in the domain IV/S4-S5 linker. Representative WT (B)
neuron expressing L858H fires five action potentials in and M1627K (C) Nav1.7 currents are shown. Cells were
response to the same current injection. (C) For the entire held at −100 mV and currents were elicited with 50-ms
population of DRG neurons studied, the firing frequency test pulses to potentials ranging from −80 to 40 mV. For
evoked by 50-pA current stimuli was 0.32 ± 0.13 Hz af- better comparison, WT and M1627K currents elicited
ter transfection with WT channels and 2.06 ± 0.79 Hz with −30 mV (D) and +25 mV (E) depolarizations are
after transfection with L858H, and the firing frequency shown superimposed. Although the rate of activation is
evoked by 100-pA stimuli was 0.89 ± 0.28 Hz after trans- not apparently altered, the decay phase is slowed for mu-
fection with WT and 3.37 ± 1.13 Hz after transfection tant channels, indicating an abnormality of channel in-
with L858H (∗, P < 0.05). (Adapted with permission activation. (Adapted with permission from Dib-Hajj and
from Rush and colleagues.54 Panels A–C are from Fig. 3 colleagues.59 Panels B–E are from Fig. 2 of this article.)
of that article.)

was dramatically shifted in the depolarizing direc- Dib-Hajj and collaborators demonstrated that the
tionby the M1627K mutation (Fig. 5C). Similar M1627K mutation reduces the threshold for gen-
changes in fast-inactivation have been seen with eration of single action potentials and increases
some40,45,46 but not all IEM mutations.42,43,47,56 The the number of action potentials in DRG neurons
ramp currents elicited with slow ramp depolar- in response to graded stimuli,59 thus showing that
izations in the M1627K PEPD mutation were sig- the mutant channel renders DRG neurons hyperex-
nificantly larger for the mutant channels than for citable (Fig. 6). These data provide a link between
the WT channels (Fig. 5D). Using current clamp, altered channel properties and the pain symptoms

Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences. 201

Familial syndromes in the Nav1.7 channel Fischer & Waxman

Figure 5. The M1627K mutation alters inactivation properties of Nav1.7. (A) Normalized peak current-voltage
relationship for WT and M1627K channels, showing that channel activation is not substantially altered by the
M1627K mutation. (B) The time constants for deactivation, which reflect the channel’s transition from an open
to a closed state, were also not significantly altered between cells expressing WT Nav1.7 or M1627K channels. (C)
Steady-state fast-inactivation of the M1627K Nav1.7 channels is shifted in a depolarizing direction. (D) The average
relative ramp current (ramp current divided by peak transient current amplitude) is larger for M1627K than for WT.
(Adapted with permission from Dib-Hajj and colleagues.59 Panels A–C are from Fig. 3 and Panel D is from Fig. 6 of
that article.)

experienced by PEPD patients. Why IEM patients conserved among most sodium channels, exclud-
experience pain in the feet and hands, triggered by ing Nav1.9. The patient described with this particu-
warmth, while PEPD patients experience pain in lar mutation had had apnea, bradycardia, and poor
the perirectal area, triggered by rectal stimuli and feeding since birth. The bradycardia episodes were
then perimandibular and/or periocular pain, is not often precipitated by touching, feeding, urination,
currently known. or defecation. As the patient grew older, the patient
also complained of episodes of pain described as
The A1632E mutation—part of a continuum “hot needles” in the feet, hands, and head, often
between IEM and PEPD precipitated by warmth and attenuated by cooling.

In 2008 a new mutation in Nav1.7, A1632E, was The A1632E mutation from this patient was
described63 in a patient with a unique mixture of shown to have biophysical characteristics common
symptoms, which included clinical characteristics to both IEM and PEPD mutations, altering ac-
of both IEM and PEPD. This mutation alters a tivation and inactivation (Fig. 7A), deactivation
conserved amino acid within the linker between (Fig. 7B), and slow ramp currents (Fig. 7C) of the
transmembrane segments S4 and S5 of domain IV, channel.63 Figure 8 shows diagrammatically how
which is close to the PEPD mutation M1627K.59,60 this particular mutation exhibits electrophysiolog-
The amino acid sequence within this loop is highly ical properties commonly seen in patients with ei-
ther PEPD or IEM characteristics.63 The A1632E

202 Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences.

Fischer & Waxman Familial syndromes in the Nav1.7 channel

Figure 6. Higher rates of neuronal firing at lower current injections are seen in M1627K cells, indicating hyperex-
citability of the mutant channel. The upper panels are the responses of a DRG neuron expressing M1627K channels,
which can be compared to responses of cells housing WT Nav1.7 channels. Cells expressing the mutant channel live
at a higher firing frequency in response to stimuli at 2× and 3× threshold and show increased maximal firing rates.
(Adapted with permission from Dib-Hajj and colleagues.59 This is Fig. 9 from that article.)

mutation and its associated phenotype suggest that intact by report. Affected individuals displayed
IEM and PEPD mutations may be part of a physi- painless burns, fractures, and injuries of the lips
ological continuum that can produce a continuum and tongue, and were reported never to have felt
of clinical pictures. pain in any part of the body, in response to any
injury or noxious stimulus. The patients did not
Channelopathy-associated insensitivity appear to exhibit autonomic or motor abnormal-
to pain ities, and reportedly had normal tear formation,
sweating ability, reflexes, and intelligence. Cox and
Subsequent to the identification of the role of the coworkers33 found that in all three of the studied
Nav1.7 sodium channel in IEM, Cox and cowork- families, distinct, homozygous nonsense mutations
ers33 reported several families in which loss-of- of Nav1.7 produced truncated, nonfunctional pro-
function mutations of Nav1.7 were associated with teins. Patch-clamping experiments, done in HEK
profound insensitivity to pain; other sensory modal- 293 cells co-expressing either WT or mutant chan-
ities were preserved and the remainder of the pa- nels together with ␤1 and ␤2 subunits, showed
tients’ central and peripheral nervous systems were a loss-of-function in cells containing the mutant

Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences. 203

Familial syndromes in the Nav1.7 channel Fischer & Waxman

Figure 8. A comparison of IEM and PEPD mutations.
This diagram plots the shifts seen in known IEM
mutations (open squares) and PEPD mutations (gray
circles). The WT control is plotted as a black diamond at
(0,0). The dotted lines through (0,0) demarcate between
positive and negative shifts and indicate the outcome
for the shifts. The A1632E mutation from a patient with
clinical characteristics of both IEM and PEPD is plotted
with the star symbol and shows shifts in activation and
inactivation common to both IEM and PEPD mutants.
The identity of each numbered symbol is as follows: 1,
T1464I (Fertleman et al., 2006); 2, V1298F (Jarecki et al.,
2008); 3, V1299F (Jarecki et al., 2008); 4, I1461T (Jarecki
et al., 2008); 5, M1627K (Fertleman, 2006); 6, I1461T
(Fertleman, 2006); 7, I136V (Cheng et al., 2008); 8, S241T
(Lampert et al., 2006); 9, F1449V (Dib-Hajj, 2005); 10,
A863P (Harty et al., 2006); 11, L858F (Han et al., 2006);
12, F216S (Choi et al., 2006); 13, L858H (Cummins et al.,
2004); and 14, I848T (Cummins et al., 2004). (Adapted
with permission from Estacion and colleagues.63 This is
Fig. 8 in that article.)

Figure 7. A1632E shifts both activation and fast inacti- channels.33 Additional families with similar loss-of-
vation of the mutant channel, as previously observed in function mutations of Nav1.7 and a similar clinical
IEM and PEPD mutations, respectively. (A) Activation picture were subsequently reported by Ahmad and
and fast inactivation curves for WT and mutant cells are colleagues32 and Goldberg and colleagues.34 The
shown. The mutant cells exhibit hyperpolarized activa-
tion and impaired fast inactivation when compared with ←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
cells expressing the WT channel. (B) The A1632E muta- Example data traces comparing the deactivation during
tion also slows deactivation, thus causing the channel to repolarization to −50 mV are shown in the inset. (C)
close more slowly than the WT channel. This feature has The ramp response is enhanced by the A1632E mutant
been observed in Nav1.7 mutations that produce IEM. channels. (Adapted with permission from Estacion and
colleagues.63 Panels A and B are from Fig. 2 and Panel C
is from Fig. 3 of that article.)

204 Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences.

Fischer & Waxman Familial syndromes in the Nav1.7 channel

remarkably dense loss of pain sensibility in these 5. Catterall, W.A., A.L. Goldin & S.G. Waxman. 2005. Inter-
patients provides strong evidence for a central func- national Union of Pharmacology. XLVII. Nomenclature
tion of Nav1.7 in human pain. and structure-function relationships of voltage-gated
sodium channels. Pharmacol. Rev. 57: 397–409.
Conclusion
6. Chen, C., V. Bharucha, Y. Chen, et al. 2002. Reduced
It is becoming clear that gain-of-function mutations sodium channel density, altered voltage dependence of
of Nav1.7 cause syndromes characterized by severe inactivation, and increased susceptibility to seizures in
pain39–47,55,59,60,63–65 while loss-of-function muta- mice lacking sodium channel beta 2-subunits. Proc. Natl.
tions in Nav1.7 produce insensitivity to pain.32–34 Acad. Sci. USA 99: 17072–17077.
Upregulated expression of Nav1.7, together with
Nav1.8, another sodium channel isoform that works 7. Qu, Y., R. Curtis, D. Lawson, et al. 2001. Differential
together with Nav1.7 to produce high-frequency modulation of sodium channel gating and persistent
firing of DRG neurons, occurs within injured ax- sodium currents by the beta1, beta2, and beta3 subunits.
ons in human painful neurons.66 These observations Mol. Cell. Neurosci. 18: 570–580.
in humans, together with observations in rodent
models that show upregulation of Nav1.7 within 8. Yu, F.H., R.E. Westenbroek, I. Silos-Santiago, et al. 2003.
nociceptive DRG neurons in response to inflam- Sodium channel beta4, a new disulfide-linked auxiliary
mation within their peripheral projection fields,67 subunit with similarity to beta2. J. Neurosci. 23: 7577–
and in which knockout of Nav1.7 in nociceptors is 7585.
associated with attenuated inflammatory pain re-
sponses,31 establish Nav1.7 as a critically impor- 9. Isom, L.L. 2000. I. Cellular and molecular biology
tant molecule along the pain pathway, where it ap- of sodium channel beta-subunits: therapeutic impli-
pears to set the gain on pain responses.27 The recent cations for pain? I. Cellular and molecular biology of
observations in humans have accelerated the search sodium channel beta-subunits: therapeutic implications
for Nav1.7-specific blockers as potential pain thera- for pain? Am. J. Physiol. Gastrointest. Liver Physiol. 278:
peutics. Whether these agents, once identified, will G349–G353.
alleviate pain in a clinically useful manner remains
to be established. 10. Isom, L.L., K.S. De Jongh, D.E. Patton, et al. 1992. Pri-
mary structure and functional expression of the beta 1
Conflicts of interest subunit of the rat brain sodium channel. Science 256:
839–842.
The authors declare no conflicts of interest.
11. Felts, P.A., S. Yokoyama, S. Dib-Hajj, et al. 1997. Sodium
References channel alpha-subunit mRNAs I, II, III, NaG, Na6 and
hNE (PN1): different expression patterns in developing
1. Devor, M. 1994. The pathophysiology of damaged pe- rat nervous system. Brain Res. Mol. Brain Res. 45: 71–
ripheral nerves. In Textbook of Pain, 2nd edn. P.D. Wall, 82.
R. Melzack, Eds.: 79–101. Churchill Livingstone. Edin-
burgh. 12. Waxman, S.G. 2000. The neuron as a dynamic elec-
trogenic machine: modulation of sodium-channel ex-
2. Nordin, M., B. Nystrom, U. Wallin & K.E. Hagbarth. pression as a basis for functional plasticity in neu-
1984. Ectopic sensory discharges and paresthesiae in pa- rons. Philos. Trans. R. Soc. Lond. B Biol. Sci. 355:
tients with disorders of peripheral nerves, dorsal roots 199–213.
and dorsal columns. Pain 20: 231–245.
13. Caffrey, J.M., D.L. Eng, J.A. Black, et al. 1992. Three types
3. Ochoa, J.L. & H.E. Torebjork. 1980. Paraesthesiae from of sodium channels in adult rat dorsal root ganglion
ectopic impulse generation in human sensory nerves. neurons. Brain Res. 592: 283–297.
Brain 103: 835–853.
14. Elliott, A.A. & J.R. Elliott. 1993. Characterization of
4. Zhang, J.M., D.F. Donnelly, X.J. Song & R.H. Lamotte. TTX-sensitive and TTX-resistant sodium currents in
1997. Axotomy increases the excitability of dorsal root small cells from adult rat dorsal root ganglia. J. Phys-
ganglion cells with unmyelinated axons. J. Neurophysiol. iol. 463: 39–56.
78: 2790–2794.
15. Kostyuk, P.G., N.S. Veselovsky & A.Y. Tsyndrenko. 1981.
Ionic currents in the somatic membrane of rat dorsal
root ganglion neurons-I. Sodium currents. Neuroscience
6: 2423–2430.

16. Roy, M.L. & T. Narahashi. 1992. Differential proper-
ties of tetrodotoxin-sensitive and tetrodotoxin-resistant

Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences. 205

Familial syndromes in the Nav1.7 channel Fischer & Waxman

sodium channels in rat dorsal root ganglion neurons. J. 30. Nassar, M.A., A. Levato, L.C. Stirling & J.N. Wood. 2005.
Neurosci. 12: 2104–2111. Neuropathic pain develops normally in mice lacking
17. Cummins, T.R. & S.G. Waxman. 1997. Downregula- both Nav1.7 and Nav1.8. Mol. Pain. 1: 24.
tion of tetrodotoxin-resistant sodium currents and up-
regulation of a rapidly repriming tetrodotoxin-sensitive 31. Nassar, M.A., L.C. Stirling, G. Forlani, et al. 2004.
sodium current in small spinal sensory neurons after Nociceptor-specific gene deletion reveals a major role
nerve injury. J. Neurosci. 17: 3503–3514. for Nav1.7 (PN1) in acute and inflammatory pain. Proc.
18. Dib-Hajj, S.D., L. Tyrrell, T.R. Cummins, et al. 1999. Two Natl. Acad. Sci. USA 101: 12706–12711.
tetrodotoxin-resistant sodium channels in human dorsal
root ganglion neurons. FEBS Lett. 462: 117–120. 32. Ahmad, S., L. Dahllund, A.B. Eriksson, et al. 2007. A stop
19. Akopian, A.N., L. Sivilotti & J.N. Wood. 1996. A codon mutation in SCN9A causes lack of pain sensation.
tetrodotoxin-resistant voltage-gated sodium channel ex- Hum. Mol. Genet. 16: 2114–2121.
pressed by sensory neurons. Nature 379: 257–262.
20. Black, J.A., S. Dib-Hajj, K. McNabola, et al. 1996. Spinal 33. Cox, J.J., F. Reimann, A.K. Nicholas, et al. 2006. An
sensory neurons express multiple sodium channel alpha- SCN9A channelopathy causes congenital inability to ex-
subunit mRNAs. Brain Res. Mol. Brain Res. 43: 117–131. perience pain. Nature 444: 894–898.
21. Dib-Hajj, S.D., J.A. Black, T.R. Cummins, et al. 1998.
Rescue of alpha-SNS sodium channel expression in 34. Goldberg, Y.P., J. MacFarlane, M.L. MacDonald, et al.
small dorsal root ganglion neurons after axotomy by 2007. Loss-of-function mutations in the Nav1.7 gene un-
nerve growth factor in vivo. J. Neurophysiol. 79: 2668– derlie congenital indifference to pain in multiple human
2676. populations. Clin. Genet. 71: 311–319.
22. Toledo-Aral, J.J., B.L. Moss, Z.J. He, et al. 1997. Iden-
tification of PN1, a predominant voltage-dependent 35. Mitchell, S.W. 1878. On a rare vaso-motor neurosis of
sodium channel expressed principally in peripheral neu- the extremities, and on the maladies with which it may
rons. Proc. Natl. Acad. Sci. USA 94: 1527–1532. be confounded. Am. J. Med. Sci. 76: 17–36.
23. Dib-Hajj, S., J.A. Black, P. Felts & S.G. Waxman. 1996.
Down-regulation of transcripts for Na channel alpha- 36. van Genderen, P.J., J.J. Michiels, J. & P. Drenth. 1993.
SNS in spinal sensory neurons following axotomy. Proc. Hereditary erythermalgia and acquired erythromelalgia.
Natl. Acad. Sci. USA 93: 14950–14954. Am. J. Med. Genet. 45: 530–532.
24. Black, J.A., T.R. Cummins, C. Plumpton, et al. 1999.
Upregulation of a silent sodium channel after periph- 37. Drenth, J.P. & S.G. Waxman. 2007. Mutations in sodium-
eral, but not central, nerve injury in DRG neurons. J. channel gene SCN9A cause a spectrum of human genetic
Neurophysiol. 82: 2776–2785. pain disorders. J. Clin. Invest. 117: 3603–3609.
25. Waxman, S.G., J.D. Kocsis & J.A. Black. 1994. Type III
sodium channel mRNA is expressed in embryonic but 38. Novella, S.P., F.M. Hisama, S.D. Dib-Hajj & S.G. Wax-
not adult spinal sensory neurons, and is reexpressed fol- man. 2007. A case of inherited erythromelalgia. Nat.
lowing axotomy. J. Neurophysiol. 72: 466–470. Clin. Pract. Neurol. 3: 229–234.
26. Baker, M.D. & J.N. Wood. 2001. Involvement of Na+
channels in pain pathways. Trends Pharmacol. Sci. 22: 39. Yang, Y., Y. Wang, S. Li, et al. 2004. Mutations in SCN9A,
27–31. encoding a sodium channel alpha subunit, in patients
27. Waxman, S.G. 2006. Neurobiology: a channel sets the with primary erythermalgia. J. Med. Genet. 41: 171–174.
gain on pain. Nature 444: 831–832.
28. Akopian, A.N., V. Souslova, S. England, et al. 1999. The 40. Dib-Hajj, S.D., A.M. Rush, T.R. Cummins, et al. 2005.
tetrodotoxin-resistant sodium channel SNS has a spe- Gain-of-function mutation in Nav1.7 in familial ery-
cialized function in pain pathways. Nat. Neurosci. 2: 541– thromelalgia induces bursting of sensory neurons. Brain
548. 128: 1847–1854.
29. Laird, J.M., V. Souslova, J.N. Wood & F. Cervero. 2002.
Deficits in visceral pain and referred hyperalgesia in 41. Cheng, X., S.D. Dib-Hajj, L. Tyrrell & S.G. Wax-
Nav1.8 (SNS/PN3)-null mice. J. Neurosci. 22: 8352– man. 2008. Mutation I136V alters electrophysiological
8356. properties of the Na(v)1.7 channel in a family with onset
of erythromelalgia in the second decade. Mol. Pain 4: 1.

42. Choi, J.S., S.D. Dib-Hajj & S.G. Waxman. 2006. Inherited
erythermalgia: limb pain from an S4 charge-neutral Na
channelopathy. Neurology 67: 1563–1567.

43. Cummins, T.R., S.D. Dib-Hajj & S.G. Waxman.
2004. Electrophysiological properties of mutant Nav1.7
sodium channels in a painful inherited neuropathy. J.
Neurosci. 24: 8232–8236.

44. Fischer, T.Z., E.S. Gilmore, M. Estacion, et al. 2009.
A novel Nav1.7 mutation producing carbamazepine-
responsive erythromelalgia. Ann. Neurol. 65: 773–741.

206 Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences.

Fischer & Waxman Familial syndromes in the Nav1.7 channel

45. Han, C., A.M. Rush, S.D. Dib-Hajj, et al. 2006. Sporadic ity and displays reduced lidocaine sensitivity. J. Physiol.
onset of erythermalgia: a gain-of-function mutation in 581: 1019–1031.
Nav1.7. Ann. Neurol. 59: 553–558. 57. Drenth, J.P., R.H. Te Morsche, S. Mansour & P.S. Mor-
timer. 2008. Primary erythermalgia as a sodium chan-
46. Harty, T.P., S.D. Dib-Hajj, L. Tyrrell, et al. 2006. Na(V)1.7 nelopathy: screening for SCN9A mutations: exclusion of
mutant A863P in erythromelalgia: effects of altered ac- a causal role of SCN10A and SCN11A. Arch. Dermatol.
tivation and steady-state inactivation on excitability of 144: 320–324.
nociceptive dorsal root ganglion neurons. J. Neurosci. 26: 58. Burns, T.M., R.H. Te Morsche, J.B. Jansen & J.P. Drenth.
12566–12575. 2005. Genetic heterogeneity and exclusion of a modi-
fying locus at 2q in a family with autosomal dominant
47. Lampert, A., S.D. Dib-Hajj, L. Tyrrell & S.G. Waxman. primary erythermalgia. Br. J. Dermatol. 153: 174–177.
2006. Size matters: Erythromelalgia mutation S241T in 59. Dib-Hajj, S.D., M. Estacion, B.W. Jarecki, et al. 2008.
Nav1.7 alters channel gating. J. Biol. Chem. 281: 36029– Paroxysmal extreme pain disorder M1627K mutation
36035. in human Nav1.7 renders DRG neurons hyperexcitable.
Mol. Pain 4: 37.
48. Djouhri, L., R. Newton, S.R. Levinson, et al. 2003. 60. Fertleman, C.R., M.D. Baker, K.A. Parker, et al. 2006.
Sensory and electrophysiological properties of guinea- SCN9A mutations in paroxysmal extreme pain disor-
pig sensory neurones expressing Nav 1.7 (PN1) Na+ der: allelic variants underlie distinct channel defects and
channel alpha subunit protein. J. Physiol. 546: 565– phenotypes. Neuron 52: 767–774.
576. 61. Jarecki, B.W., P.L. Sheets, J.O. Jackson, 2nd & T.R. Cum-
mins. 2008. Paroxysmal extreme pain disorder mutations
49. Sangameswaran, L., L.M. Fish, B.D. Koch, et al. 1997. within the D3/S4-S5 linker of Nav1.7 cause moderate
A novel tetrodotoxin-sensitive, voltage-gated sodium destabilization of fast inactivation. J. Physiol. 586: 4137–
channel expressed in rat and human dorsal root gan- 4153.
glia. J. Biol. Chem. 272: 14805–14809. 62. Fertleman, C.R., C.D. Ferrie, J. Aicardi, et al. 2007. Parox-
ysmal extreme pain disorder (previously familial rectal
50. Cummins, T.R., J.R. Howe & S.G. Waxman. 1998. Slow pain syndrome). Neurology 69: 586–595.
closed-state inactivation: a novel mechanism underlying 63. Estacion, M., S.D. Dib-Hajj, P.J. Benke, et al. 2008.
ramp currents in cells expressing the hNE/PN1 sodium NaV1.7 gain-of-function mutations as a continuum:
channel. J. Neurosci. 18: 9607–9619. A1632E displays physiological changes associated with
erythromelalgia and paroxysmal extreme pain disorder
51. Herzog, R.I., T.R. Cummins, F. Ghassemi, et al. 2003. mutations and produces symptoms of both disorders. J.
Distinct repriming and closed-state inactivation kinetics Neurosci. 28: 11079–11088.
of Nav1.6 and Nav1.7 sodium channels in mouse spinal 64. Drenth, J.P., R.H. te Morsche, G. Guillet, et al. 2005.
sensory neurons. J. Physiol. 551: 741–750. SCN9A mutations define primary erythermalgia as a
neuropathic disorder of voltage gated sodium channels.
52. Renganathan, M., T.R. Cummins & S.G. Waxman. 2001. J. Invest. Dermatol. 124: 1333–1338.
Contribution of Na(v)1.8 sodium channels to action po- 65. Waxman, S.G. & S. Dib-Hajj. 2005. Erythermalgia:
tential electrogenesis in DRG neurons. J. Neurophysiol. molecular basis for an inherited pain syndrome. Trends
86: 629–640. Mol. Med. 11: 555–562.
66. Black, J.A., L. Nikolajsen, K. Kroner, et al. 2008. Multiple
53. Harper, A.A. & S.N. Lawson. 1985. Electrical proper- sodium channel isoforms and mitogen-activated protein
ties of rat dorsal root ganglion neurones with different kinases are present in painful human neuromas. Ann.
peripheral nerve conduction velocities. J. Physiol. 359: Neurol. 64: 644–653.
47–63. 67. Black, J.A., S. Liu, M. Tanaka, et al. 2004. Changes in
the expression of tetrodotoxin-sensitive sodium chan-
54. Rush, A.M., S.D. Dib-Hajj, S. Liu, et al. 2006. A single nels within dorsal root ganglia neurons in inflammatory
sodium channel mutation produces hyper- or hypoex- pain. Pain 108: 237–247.
citability in different types of neurons. Proc. Natl. Acad.
Sci. USA 103: 8245–8250.

55. Choi, J.S., L. Zhang, S.D. Dib-Hajj, et al. 2009.
Mexiletine-responsive erythromelalgia due to a new
Na(v)1.7 mutation showing use-dependent current fall-
off. Exp. Neurol. 216: 383–389.

56. Sheets, P.L., J.O. Jackson, 2nd, S.G. Waxman, et al. 2007.
A Nav1.7 channel mutation associated with hereditary
erythromelalgia contributes to neuronal hyperexcitabil-

Ann. N.Y. Acad. Sci. 1184 (2010) 196–207 c 2009 New York Academy of Sciences. 207


Click to View FlipBook Version